A Double Blind, Randomized, Placebo Controlled, Parallel Group Dose-range Exploration Study of Sativex® in Relieving Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy.
A Double Blind, Randomized, Placebo Controlled, Parallel Group Dose-range Exploration Study of Sativex® in Relieving Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy.
The purpose of this study is to determine the effective dose range and to demonstrate a non-effective dose range of Sativex in patients with advanced cancer, who experience inadequate pain relief even though they are on optimized chronic opioid therapy.
Inclusion Criteria:
Exclusion Criteria:
Fountain Valley, California 92708, United States
Hagerstown, Maryland 21740, United States
Praha 8 - Liben, 180 81, Czechia
Andhra Pradesh, 500 082, India
Hyderabaad, 500033, India
Hyderabaad, 500034, India
Madhya Pradesh, 452 008, India
Madhya Pradesh, 462 001, India
Rajasthan, 302 013, India
Edyty Jakubow, Poland
Hatfield, Pretoria, 0083, South Africa
Hatfield, Pretoria, 0083, South Africa
Feixa, Llarga, Sn, 08907, Spain